Imugene Limited
IUGNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $113,407 | $257,283 | $446,432 | $606,002 |
| - Cash | $21,935 | $33,742 | $93,108 | $139,392 |
| + Debt | $10,651 | $15,757 | $1,547 | $6,491 |
| Enterprise Value | $102,123 | $239,298 | $354,872 | $473,101 |
| Revenue | $3,138 | $1,258 | -$3,098 | $8,068 |
| % Growth | 149.5% | 140.6% | -138.4% | – |
| Gross Profit | $3,138 | $1,258 | -$3,098 | $8,068 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$18,901 | -$48,522 | -$77,306 | -$69,152 |
| % Margin | -602.3% | -3,857.1% | 2,495.3% | -857.1% |
| Net Income | -$20,683 | -$48,339 | -$80,966 | -$68,715 |
| % Margin | -659% | -3,842.5% | 2,613.5% | -851.7% |
| EPS Diluted | -0.094 | -0.22 | -0.38 | -0.34 |
| % Growth | 57.2% | 42.1% | -11.8% | – |
| Operating Cash Flow | -$36,947 | -$38,622 | -$48,901 | -$48,421 |
| Capital Expenditures | $3,214 | -$10,763 | $2,042 | -$11,497 |
| Free Cash Flow | -$33,733 | -$49,385 | -$46,859 | -$59,919 |